Skip to main content

Market Overview

Rookie Traders Get Crushed By Cocrystal Pharma Stock

Share:
Rookie Traders Get Crushed By Cocrystal Pharma Stock

The trading in biotechnology company Cocrystal Pharma, Inc. (NASDAQ: COCP) is a good example of how inexperienced traders can lose a lot of money.

What Happened: Cocrystal closed Tuesday at $2.14, a gain of over 70%. At one point during the day, shares reached $3.46, which was about 270% higher than the previous close.

This move was driven by news that the company was going to offer 26 million new shares to the public priced at $1.54 a share.

It appears as though all the investors who bought COCP and didn’t sell are going to lose money. Wednesday morning, shares are trading around $1.50.

See Also: Cocrystal Pharma Shares Plunge On $40M Equity Raise At 28% Discount

Why It's Important: Traders who think a company offering new shares is a good thing are usually wrong, as offering shares is a typically bearish sign for a company.

When a company issues new shares, they typically do so because the insiders and their bankers think shares are overvalued. They sell because they're taking advantage of what they perceive to be a premium in the share price.

If the company thinks shares are a good sell at $1.54, why would an investor who doesn’t know much about the company think that they're worth more? Rookie traders could save money if they learn this valuable lesson.

cocp.png

 

Related Articles (COCP)

View Comments and Join the Discussion!

Posted-In: News Penny Stocks Technicals Offerings Markets Trading Ideas Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com